Related Experiment Video

Updated: Nov 20, 2025

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.0K

TPP-based mitocans: a potent strategy for anticancer drug design

Jiayao Wang1, Jiaqi Li1, Yumei Xiao1

  • 1College of science , China Agriculture University , Haidian District 100089 , China . Email: qinzhaohai@263.net ; Tel: +86 130 0199 1198.

RSC Medicinal Chemistry
|January 22, 2021
PubMed

Insights

Mitochondria are key regulators of cancer cell metabolism and development. Targeting these metabolic abnormalities, particularly with triphenylphosphonium (TPP)-based drugs, offers a promising strategy for novel anticancer therapies.

Area of Science:

  • Oncology
  • Mitochondrial Biology
  • Drug Discovery

Background:

  • Cancer poses a significant global health challenge with increasing incidence.
  • Cancer cells display distinct metabolic dysfunctions, including altered glycolysis, oxidative phosphorylation, and elevated reactive oxygen species.
  • Mitochondria play a crucial role in regulating cancer cell physiology, making them attractive therapeutic targets.

Purpose of the Study:

  • To systematically review current mitochondrial anticancer drugs.
  • To highlight the potential of targeting mitochondrial metabolic abnormalities for cancer treatment.
  • To discuss the advantages of triphenylphosphonium (TPP) in developing mitochondria-targeted anticancer agents (mitocans).

Main Methods:

  • Literature review of scientific publications on mitochondrial anticancer drugs.
  • Analysis of the role of mitochondria in cancer metabolism and tumorigenesis.
  • Examination of triphenylphosphonium (TPP) as a moiety for mitochondrial drug targeting.

Main Results:

  • Mitochondria are central to cancer's abnormal metabolism and survival mechanisms.
  • Targeting mitochondrial pathways presents a viable strategy for anticancer drug development.
  • Triphenylphosphonium (TPP) effectively targets mitochondria, enhancing the efficacy of mitocans.

Conclusions:

  • Mitochondria represent a critical target for novel anticancer drug design.
  • Triphenylphosphonium (TPP)-based mitocans demonstrate significant potential for cancer therapy.
  • Further research into mitochondria-targeted therapies could lead to more effective cancer treatments.

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

13.7K
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
866